MedEquities Realty Trust (NYSE:MRT) had its price target lowered by KeyCorp from $13.00 to $12.00 in a research report released on Monday, April 16th. The firm currently has an overweight rating on the financial services provider’s stock. KeyCorp also issued estimates for MedEquities Realty Trust’s FY2018 earnings at $1.20 EPS.
MRT has been the subject of a number of other reports. B. Riley set a $13.00 price target on shares of MedEquities Realty Trust and gave the stock a buy rating in a report on Thursday, February 22nd. ValuEngine cut shares of MedEquities Realty Trust from a buy rating to a hold rating in a report on Monday, April 2nd. Cantor Fitzgerald restated a buy rating and issued a $14.00 price target on shares of MedEquities Realty Trust in a report on Wednesday, February 21st. Citigroup reduced their price objective on shares of MedEquities Realty Trust from $12.00 to $10.00 and set a neutral rating for the company in a report on Thursday, March 1st. Finally, Zacks Investment Research cut shares of MedEquities Realty Trust from a buy rating to a hold rating in a report on Wednesday, January 3rd. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. MedEquities Realty Trust has an average rating of Hold and a consensus target price of $12.33.
MRT opened at $9.90 on Monday. MedEquities Realty Trust has a twelve month low of $9.67 and a twelve month high of $13.06. The firm has a market cap of $316.95, a PE ratio of 8.72 and a beta of -0.22.
Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. LSV Asset Management bought a new position in shares of MedEquities Realty Trust during the fourth quarter valued at about $103,000. JPMorgan Chase & Co. bought a new position in shares of MedEquities Realty Trust during the third quarter valued at about $118,000. Bank of New York Mellon Corp lifted its position in shares of MedEquities Realty Trust by 9.3% during the third quarter. Bank of New York Mellon Corp now owns 117,403 shares of the financial services provider’s stock valued at $1,379,000 after purchasing an additional 9,960 shares in the last quarter. Wells Fargo & Company MN raised its position in MedEquities Realty Trust by 43.4% in the third quarter. Wells Fargo & Company MN now owns 35,366 shares of the financial services provider’s stock worth $416,000 after acquiring an additional 10,700 shares during the period. Finally, MetLife Investment Advisors LLC bought a new stake in MedEquities Realty Trust in the fourth quarter worth about $120,000. 91.87% of the stock is currently owned by institutional investors.
MedEquities Realty Trust Company Profile
MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.
Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.